TIMP1 and neoplasm: In addition, staining for the tissue inhibitor of metalloproteinases, TIMP-1, as one of the endogenous MMP inhibitors, showed reduction in perilesional skin as well as tumor samples as compared with normal healthy skin (Figure 8D), which may support an increasing imbalance in favor of the degradative phenotype with vemurafenib treatment.